ICLR
$100.49
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
Recent News
DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates
Motion Acquisition (DCGO) delivered earnings and revenue surprises of -457.90% and +6.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates
Beauty Health (SKIN) delivered earnings and revenue surprises of +7.69% and +5.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies (NYSE:A) while trimming its price target on Icon PLC (NASDAQ:ICLR) following a turbulent earnings season for the sector. Alongside those moves, the firm named Agilent its top tools pick, Natera (NASDAQ:NTRA) its top diagnostics ... Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More
Polen Global Growth Strategy Sold ICON plc (ICLR) Due to Short-Term Growth Challenges
Polen Capital, an investment management company, released its fourth-quarter 2025 investor letter for “Polen Global Growth Strategy”. A copy of the letter can be downloaded here. The fourth quarter of 2025 seemed to be like the entire year. The stock market experienced a severe 5% sell-off in the fourth quarter but quickly recovered to all-time […]
A Look At ICON (ICLR) Valuation After Revenue Recognition Probe And Withdrawn 2025 Guidance
ICON (NasdaqGS:ICLR) is back in focus after its Audit Committee launched an internal review of past revenue recognition, prompting withdrawn 2025 guidance, a delayed earnings release, mixed analyst reactions, and fresh securities law investigations. See our latest analysis for ICON. The share price has recently bounced 4.21% over the last week to US$110.60 after a sharp 34.13% one-month share price decline. The 1 year total shareholder return decline of 40.27% highlights how pressure has...